sertindole

This page covers all sertindole drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting 5-hydroxytryptamine receptor 2C, Estrogen receptor.

Targets

5-hydroxytryptamine receptor 2C · Estrogen receptor

Marketed (1)

• Zerdol · H. Lundbeck A/S · Neuroscience

Phase 3 pipeline (1)

• di indolylmethane (DIM) · New York Presbyterian Hospital · Oncology
  DIM is a natural compound that acts as an estrogen receptor antagonist and a weak estrogen receptor agonist.

Patent intelligence

• indole patent landscape — aggregated cliff calendar, attackable patents, originator estates